168 related articles for article (PubMed ID: 25246408)
1. In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates.
Liao Y; Yang S; Cong L; Lu X; Ao J; Yang R
Antimicrob Agents Chemother; 2014 Dec; 58(12):7615-6. PubMed ID: 25246408
[No Abstract] [Full Text] [Related]
2. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Li H; Lu Q; Wan Z; Zhang J
Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
[TBL] [Abstract][Full Text] [Related]
3. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
4. In vitro interaction of itraconazole with amphotericin B, caspofungin, and terbinafine against clinical isolates of Trichosporon asahii.
Li H; Qiao J; Wan Z; Zhang J
Mycopathologia; 2011 May; 171(5):345-8. PubMed ID: 21153882
[TBL] [Abstract][Full Text] [Related]
5. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.
Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL
PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.
Cong L; Liao Y; Yang S; Yang R
Mycopathologia; 2017 Oct; 182(9-10):829-837. PubMed ID: 28144822
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activities of tacrolimus in combination with antifungal agents against fluconazole-susceptible and fluconazole-resistant Trichosporon asahii isolates.
Kubiça TF; Denardi LB; Azevedo MI; Oliveira V; Severo LC; Santurio JM; Alves SH
Braz J Infect Dis; 2016; 20(6):539-545. PubMed ID: 27697432
[TBL] [Abstract][Full Text] [Related]
8. Quinacrine inhibits Candida albicans growth and filamentation at neutral pH.
Kulkarny VV; Chavez-Dozal A; Rane HS; Jahng M; Bernardo SM; Parra KJ; Lee SA
Antimicrob Agents Chemother; 2014 Dec; 58(12):7501-9. PubMed ID: 25288082
[TBL] [Abstract][Full Text] [Related]
9. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of antifungal combinations against Candida albicans biofilms.
Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
[TBL] [Abstract][Full Text] [Related]
11. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
[TBL] [Abstract][Full Text] [Related]
12. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.
Di Bonaventura G; Pompilio A; Picciani C; Iezzi M; D'Antonio D; Piccolomini R
Antimicrob Agents Chemother; 2006 Oct; 50(10):3269-76. PubMed ID: 17005804
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates.
Cong L; Liao Y; Yang S; Yang R
PLoS One; 2016; 11(12):e0167903. PubMed ID: 27930704
[TBL] [Abstract][Full Text] [Related]
15. Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.
Simitsopoulou M; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2014 Aug; 58(8):4953-6. PubMed ID: 24890585
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
Liu W; Li L; Sun Y; Chen W; Wan Z; Li R; Liu W
Antimicrob Agents Chemother; 2012 Dec; 56(12):6414-6. PubMed ID: 23027186
[TBL] [Abstract][Full Text] [Related]
17. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
18. Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil.
Menezes EA; Marinho JA; Angelo MR; Cunha Mda C; Cunha FA; Vasconcelos Júnior AA
Rev Inst Med Trop Sao Paulo; 2012; 54(1):1-3. PubMed ID: 22370746
[TBL] [Abstract][Full Text] [Related]
19. Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients.
Montoya AM; Elizondo-Zertuche M; Treviño-Rangel RJ; Becerril-García M; González GM
Rev Iberoam Micol; 2018; 35(1):22-26. PubMed ID: 29287630
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of amphotericin-B, voriconazole and caspofungin against Candida guilliermondii biofilms, isolated from dentals units water pipes, under different growth phases.
Mazari W; Boucherit-Otmani Z; Boucherit K
J Mycol Med; 2015 Mar; 25(1):57-62. PubMed ID: 25533329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
